CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public comments due by June 26.

When Congress adopted the Inflation Reduction Act (IRA) in 2022, creating the Medicare Drug Price Negotiation Program (MDPNP), the bill did

The president signed an executive order that gives Health and Human Services Secretary Robert F. Kennedy Jr. 30 days to lower drug prices.

President Donald Trump signed an executive order aimed at cutting prescription drug prices. The plan won’t be limited to Medicare prescriptions but will also target medications covered by Medicaid and private insurance.

Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the amount of Medicare spending subject to price negotiation by billions of dollars annually.

The cost of prescription drugs have risen rapidly despite policymakers pledging to fix the issue. They climbed nearly 40% since 2014, according to data from GoodRx.

The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible for a third round of Medicare price negotiations by early February next year.

Trump claimed his proposed plan to tie drug prices to those paid in foreign nations would lower by up to 90% the payments by the U.S., although experts said it’s unclear if the plan is legal